George Barth Geller Distinguished Professor of Immunology
Professor of Surgery
Professor in Immunology
Professor of Pathology
Office:
203 Research Drive, Rm 433B, Box 2606, Durham, NC 27710
Campus Mail:
DUMC Box 2606 Med Ctr, Durham, NC 27710
Education and Training
- M.D., University of California - Los Angeles, 1983
In the News
- Higher Rates of Alzheimer’s Deaths, Hospitalizations Correlate with Air PollutionJuly 13, 2021
- BRIEF-OncoSec Appoints Oncologist And Immunologist Herbert Kim Lyerly To Board Of DirectorsApril 20, 2020
- Innovative Model Allows Researchers to Watch Cancer Cells Spread in Colon Before Cancer Is Even DetectedDecember 2, 2019
- Air pollution is as harmful as smoking a pack a dayAugust 19, 2019
- Vaccine for Deadly Form of Breast Cancer Shows Early PromiseMarch 11, 2019
- After Florence: Duke Faculty Contribution to Relief PlanningSeptember 24, 2018
- N.C. Residents Living Near Large Hog Farms Have Elevated Disease, Death RisksSeptember 18, 2018
- Despite Studies, Health Effects of Coal-Burning Power Plants Remain UnknownSeptember 18, 2018
- When patients set science's research agenda, who loses?September 17, 2014
- Dr. Kim Lyerly: Air quality shapes public healthJune 25, 2014
- Cleaner air contributes to fewer asthma, emphysema deathsJune 23, 2014
- Cleaner Air, Better Health, Cost SavingsJune 23, 2014
- Duke scientists report air pollution controls linked to lower N.C. death ratesJune 23, 2014
Selected Grants
- Visualizing tumor heterogeneity in an immune intact and autochthonous mouse model of breast cancer
- Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory
- Mouse Paint: A massively combinatorial approach for illuminating tumor heterogeneity in True Color
- Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers
- Duke University Program in Environmental Health
- Viral Oncology Training Grant
- Beyond PD1: An immunotherapeutic strategy to stimulate and enable both T-cell and B-cell responses in immunosuppressive and non-mutated metastatic breast cancer
- Determinants of geographic disparities in mortality and multimorbidity in the U.S.
- Hebei Bio-High Technology Visiting Researcher Training
- Defining the Rules of Breast Cancer Cell Traffic Through Bone
- Detection and Elimination of Oncogenic Signaling Networks in Pre-malignant and Malignant Cells with Magnetic Resonance Imaging
- Developing a HER3 Vaccine to Prevent Resistance to Endocrine Therapy
- Translational Research in Surgical Oncology
- A Molecular Framework for Understanding DCIS
- Establishing the molecular and cellular mechanisms of Lgr5 signaling for controlling cancer stem cell behavior
- Mechanisms of Action and Resistance to PD-1 Immunotherapies in Breast Cancer
- Immunotherapeutic Targeting of a Therapy Resistant Oncogenic HER2 Isoform
- Investigating Adaptive Immune Recognition of Dormant Disseminated Tumor Cells
- Inhibition of Wnt/B-Catenin Signaling in Colorectal Cancer Therapy
- Duke University Program in Environmental Health
- 3D Biology Signatures defined by Nanostring Max System
- Duke-Komen Fundamentals Training for Patient Advocates - AAADV
- A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes
- AAADV Fundamentals
- Advancing Immunology in Dogs with Naturally-occurring Invasive Bladder Cancer, a Relevant Model to Improve Immunotherapy Across Molecular Cancer Subtypes in Humans
- A Simple System for Early Detection of Breast Cancer
- AAADV Scholars
- AAADV Scholars
- AAADV Scholars
- AAADV Workshop
- Cancer Biology Training Grant
- Integrating Population and Basic Science in Cancer Research
- Clinical Oncology Research Career Development Program
- 2015 Accelerating Anticancer Agent Development and Validation Workshop
- A Cancer Rainbow Mouse for the Simultaneous Assessment of Multiple Oncogenes
- Administrative Supplement for Recruitment of New Faculty
- Immunotherapy with High Frequency, CEA Specific
- SPORE in Breast Cancer
- Cancer Center Core Grant Supplement - Accelerating Anticancer Agent Development Workshop
- Cancer Center Core Grant Supplement - Accelerating Anticancer Agent Dev Workshop
- Targeting hCG-beta for Breast Cancer Immunotherapy
- Developing Biomarker-Based Prognostics in Breast Cancer
- Vaccination with Regulatory T Cell Depletion
- Markers of short term breast cancer risk in FNA
- Novel Biomarkers for Aromatase Inhibitor Therapy
- Phase II trial of Cetuximab & Carboplatin in Basal-like Breast Cancer
- Biomarker Studies for Novel Anti-Cancer Agents
- Dendritic Cell Based Immunotherapy
- Immunotherapy using peptide MHC tetramer isolated Tcells
- Dendritic Cell Mobilization and Active Immunotherapy
- Immunologic Correlates of Effective Immunizations for Cancer Vaccines
- Planning a Duke Academic Public Private Partnership Program (AP4) Center
- Phase II Trial of Estradiol Therapy for Advanced Breast Cancer
- Mentored Oriented Research Career Development Award
- Cancer Center Core Grant - CURE Supplment
- Immunotherapy of Prostate Cancer with Tumor Vaccines
- RNA Transfected Dendritic Cells for Cancer Immunotherapy
- Dexasome Based Immunotherapy of Lung Cancer
- Immunotherapy with TRICOM Modified Dendritic Cells
- Cytomation MoFlo High Performance Flow Cytometer
- Dendritic Cell Immunotherapy For Breast Cancer
- Cancer Immunotherapy With Rna Pulsed Dendritic Cells
- Immunotherapy With Peptide Pulsed Dendritic Cells
- Immunotherapy with peptide pulsed dendritic cell
- Viral Control And Immune Reconstitution In Hiv Infection
- Viral Control & Immune Reconstitution In Hiv Infection
- Immunotherapy Of Breast Cance5 With Gene Modified Tumor
- Immunotherapy Of Breast Cancer With Gene Modified Tumor
- Immunotherapy of Breast Cancer with Gene Modified Tumors
- DUMC AIDS Malignancy Program
- Dumc Aids Malignancy Program
- Spore In Breast Cancer
- Spore In Breast Cancer
- Surrogate Markers Of Tumor Specific Immunity
- Preclinical Development Of Rna Decoys
- Adoptive Immunotherapy For Aids Lymphoma
- Cellular Immunity Against Post-Transplant Lymphoma